Related Experiment Video
Updated: Feb 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A rare case of apical hypertrophic cardiomyopathy (AHCM)
Seyed Abbas Mirabbasi1, Koroush Khalighi1,2, Suresh Mukkamala1
1Department of Medicine, Easton Hospital, Drexel University School of Medicine, Easton, PA, USA.
Insights
Apical hypertrophic cardiomyopathy (AHCM) is a rare condition causing left ventricular thickening. This case highlights key ECG and echo findings crucial for diagnosing AHCM, even with nonspecific symptoms.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Apical hypertrophic cardiomyopathy (AHCM) is a distinct form of hypertrophic cardiomyopathy (HCM) characterized by distal left ventricular wall thickening.
- While prevalent in Japan (15% of HCM cases), its incidence in the USA is lower (approx. 3% of HCM cases).
Observation:
- A 46-year-old woman with hypertension presented with dyspnea and orthopnea.
- Electrocardiogram (ECG) revealed left ventricular hypertrophy (LVH) and diffuse T-wave inversions.
- Ventriculography demonstrated severe septal hypertrophy extending to the apex, causing a significant pressure gradient.
Findings:
- Diagnostic findings confirmed severe concentric LVH with near obliteration of the left ventricular cavity.
- A significant pressure gradient (≥160 mmHg) was noted from the apex to the mid-septal region.
- These results were consistent with a diagnosis of apical hypertrophic cardiomyopathy.
Implications:
- Despite variable clinical presentations, characteristic ECG and echocardiogram findings are vital for AHCM diagnosis.
- The patient remained asymptomatic for 2.5 years following treatment with verapamil and metoprolol.
- Early and accurate diagnosis through hallmark findings can guide effective management strategies for AHCM.
Abstract:
Apical hypertrophic cardiomyopathy is a rare form of hypertrophic cardiomyopathy that involves thickening of the distal portion of the left ventricular wall. Most commonly seen in the Japan, with a prevalence rate of about 15% of all HCM patient, its incidence in the USA is approximately 3% of HCM cases. We report a case of a 46-year-old woman with history of hypertension who presented to emergency department with worsening dyspnea and orthopnea with features of left ventricular hypertrophy (LVH) and diffuse large T-wave inversions in the lateral leads on a 12-lead ECG. Further work up revealed severe concentric LVH, with near obliteration of the LV cavity. Ventriculogram showed severe symmetric hypertrophy of the mid to lower septum, extending to the apex of left ventricle with significant pressure gradient of at least 160 mmHg across the apex to mid septal cavity, with no significant gradient across the left ventricular outflow tract. These findings were consistent with apical hypertrophic cardiomyopathy. She was treated with verapamil and metoprolol and has remained asymptomatic over last 2.5 years of follow-up. Although the clinical presentation of AHCM can be variable and nonspecific; however, hallmark findings on ECG and echo can be extremely important in its diagnosis. Abbreviations: AHCM: Apical hypertrophic cardiomyopathy; ECG: Electrocardiogram; LVH: Left ventricular hypertrophy; LVOT: Left ventricular outflow tract.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction

